Kelly Lyn Warfield

USPTO Granted Patents = 13 (Patent Applications = 12)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 28(Granted Patents)

Company Filing History:

7 out of 444

Alnylam Pharmaceuticals, Inc.

patents

6 out of 8,686

US Government As Represented by the Secretary of the Army

patents

2 out of 5

Emergent Virology LLC

patents

4. 2 out of 9

Integrated Biotherapeutics, Inc.

patents

5. 1 out of 3

The United States of America As Represented by the Army

patents

where one patent can have more than one assignee

Years Active: 2010-2019

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10428022 - Iminosugars useful for the treatment of viral diseases (2019-10-01),

2. 10023848 - Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides (2018-07-17),

3. 9623016 - Antibacterial compounds (2017-04-18),

4. 9187516 - Compositions and methods for inhibiting expression of a gene from the Ebola virus (2015-11-17),

5. 9109036 - Immunogenic composition comprising alpha-hemolysin oligopeptides (2015-08-18),

6. 8912316 - Compositions and methods for inhibiting expression of CD45 gene (2014-12-16),

7. 8735369 - Compositions and methods for inhibiting expression of a gene from the Ebola virus (2014-05-27),

8. 8354390 - Compositions and methods for inhibiting expression of a gene from the ebola virus (2013-01-15),

9. 8288525 - Compositions and methods for inhibiting expression of CD45 gene (2012-10-16),

10. 7999001 - Antiviral compounds and methods of using thereof (2011-08-16),

11. 7973020 - Compositions and methods for inhibiting expression of a gene from the ebola virus (2011-07-05),

12. 7759320 - Compositions and methods for inhibiting expression of a gene from the Ebola (2010-07-20),

13. 7682618 - Generation of virus-like particles and use as panfilovirus vaccine (2010-03-23),

Title: Exploring the Innovations of Kelly Lyn Warfield

Introduction

Kelly Lyn Warfield, an accomplished inventor based in Adamstown, MD, has made significant strides in the field of biotechnology. With an impressive portfolio boasting 13 patents, Warfield has contributed to innovations that hold the potential to transform treatments for viral infections and enhance immunogenic responses.

Latest Patents

Warfield's latest inventions include groundbreaking patents on iminosugars and immunogenic compositions. The patent titled "Iminosugars useful for the treatment of viral diseases - Formula IA" focuses on utilizing iminosugars to combat viral infections. Another notable patent is the "Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides," which provides innovative methods for inducing immune responses against infections associated with PVL. These patents demonstrate Warfield's commitment to developing effective treatment strategies in the medical field.

Career Highlights

Throughout his career, Warfield has worked with leading organizations, including Alnylam Pharmaceuticals, Inc. and The United States of America, as represented by the Secretary of the Army. His work in these arenas has amplified the impact of his inventions, enabling advancements in therapeutic approaches to viral diseases.

Collaborations

Warfield's success is also attributed to his collaborations with noteworthy colleagues, including Sina Bavari and Pamela Tan. Working alongside these professionals has allowed for the exchange of ideas and expertise, further enriching the quality and applicability of Warfield's research.

Conclusion

The contributions of Kelly Lyn Warfield to the field of biotechnology showcase the power of innovation in addressing pressing health challenges. With a remarkable body of work and a commitment to advancing medical science, Warfield continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.